Piramal Pharma: Board Meeting Intimation for Intimation As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (''Listing Regulations'')

Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2024